So, Selumetinib is this MEK inhibitor. It’s mainly used to treat a condition called neurofibromatosis type 1 when these plexiform neurofibromas start causing issues. It works by actually stopping something called MEK signaling.
The drug comes in two types, a 10 mg dose and a 25 mg one, in capsule form. The recommended dose for adult patients is 25 mg/m² twice daily, and it should be taken on an empty stomach. The capsules come in bottles with 60 capsules each in one package.
